ArchPoint Investors

Position in CLYM — Climb Bio, Inc.

CIK 1483472 CORAL GABLES, FL

Position in CLYM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,680,856

+$849,266 QoQ

Shares Held

128,900

+6.2% QoQ

Ownership

0.224%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#44

of 108 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ArchPoint Investors holds $5,579,929 across 5 Biotechnology names. CLYM ranks #2 (30.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RGNX	REGENXBIO Inc.	222,278	$2,662,890
2	CLYM	Climb Bio, Inc. This page	128,900	$1,680,856
3	ABCL	AbCellera Biologics Inc.	115,055	$903,181
4	SLDB	Solid Biosciences Inc.	31,326	$312,946
5	IVVD	Invivyd, Inc.	23,000	$20,056

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,680,856	128,900	+6.2%	Shares	Sole	2026-08-13
2026-03-31	$831,590	121,400	0.0%	Shares	Sole	2026-05-14
2025-12-31	$485,600	121,400	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.